Try our mobile app

Published: 2022-10-27 07:00:12 ET
<<<  go to INMD company page
EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1

Exhibit 99.1

InMode Reports Third Quarter 2022 Financial Results; Record Quarterly Revenue of
$121.2 M, Represents 29% Year-Over-Year Growth

YOKNEAM, Israel, Oct. 27, 2022--InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2022.
 
Third Quarter 2022 Highlights:
 
Record quarterly revenue of $121.2 million, an increase of 29% compared to the third quarter of 2021: InMode’s proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments represented 82% of quarterly revenues, while 11% came from InMode’s hands-free platforms and 7% from InMode’s traditional laser and non-invasive RF platforms.
GAAP net income of $48.8 million, compared to $44.7 million in the third quarter of 2021; Record *non-GAAP net income of $56.6 million, compared to $47.9 million in the third quarter of 2021.
GAAP diluted earnings per share of $0.58, compared to $0.52 in the third quarter of 2021; Record *non-GAAP diluted earnings per share of $0.66, compared to $0.55 in the third quarter of 2021.
Quarterly revenues from consumables and service of $13.9 million, an increase of 53% compared to the third quarter of 2021.
Total cash position of $486.4 million as of September 30, 2022, including cash and cash equivalents, marketable securities, and short-term bank deposits.

U.S. GAAP Results
(U.S. dollars in thousands, except for per share data)
 
Q3 2022
Q3 2021
Revenues
$121,232
$94,176
Gross Margins
85%
85%
Net Income
$48,789
$44,718
Earnings per Diluted Share
$0.58
$0.52
*Non-GAAP Results
(U.S. dollars in thousands, except for per share data)
 
Q3 2022
Q3 2021
Gross Margins
85%
86%
Net Income
$56,646
$47,910
Earnings per Diluted Share
$0.66
$0.55

*Please refer to “Use of Non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP financial results exclude share-based compensation adjustments.
 
Management Comments
 
“Once again, we reported a record quarter with 29% top line growth and high profitability. Demand has remained strong despite the anticipated seasonality and the return of summer travel, and this positive momentum continues into Q4. We’re very happy with the successful market endorsement of our strategy as we expand from aesthetics into wellness and improved quality of life categories. We started with the EmpowerRF and we will continue with other categories such as ophthalmology, ENT and others. The EmpowerRF platform for women’s health has exceeded our optimistic expectations, which leads us to increase its revenue target yet again by 33% to $40 million for this year. In addition, we will continue to expand globally and plan on opening two new subsidiaries in Asia and Europe by mid 2023,” said Moshe, Mizrahy, Chairman and Chief Executive Officer.


Shakil Lakhani, President of InMode North America, commented on the financial results: “Our performance in North America continues to be the major growth engine for the company, with an emphasis on the Morpheus 8 becoming one of the most popular minimally invasive procedures. We’ve continued to invest in increasing our brand awareness, including adding Eva Longoria as our new brand ambassador, which is another sign of our commitment to customers and to positive consumer perception.”

“We’ve seen growing adoption of our EmpowerRF platform by an increased number of women’s health and wellness physicians across the U.S. and Canada. The success in improving women’s quality of life is meaningful to InMode, and we intend building on its momentum as we capture more share in this important market,” said Dr. Spero Theodorou, Chief Medical Officer.

Third Quarter 2022 Financial Results
 
Total revenues for the third quarter of 2022 reached $121.2 million, an increase of 29% compared to the third quarter of 2021.

“Sales of disposables continued to grow year over year and contributed more to the revenue mix, as our platforms are being used more frequently by our customers. Additionally, we successfully increased our gross margins back to the 85% target range,” said Yair Malca, Chief Financial Officer.

GAAP gross margin for the third quarter of 2022 was 85%, like in the third quarter of 2021. *Non-GAAP gross margin for the third quarter of 2022 was 85% and 86% for the third quarter of 2021.

GAAP operating margin for the third quarter of 2022 was 44%, compared to a gross operating margin of 48% in the third quarter of 2021. *Non-GAAP operating margin for the third quarter of 2022 and for the third quarter of 2021 was 51%. The decrease in GAAP operating margin is primarily attributable to change in share-based compensation expense.
 
InMode reported GAAP net income of $48.8 million, or $0.58 per diluted share, in the third quarter of 2022, compared to $44.7 million, or $0.52 per diluted share, in the third quarter of 2021. On a *non-GAAP basis, InMode reported net income of $56.6 million, or $0.66 per diluted share, in the third quarter of 2022, compared to $47.9 million, or $0.55 per diluted share, in the third quarter of 2021.
 

 
2022 Financial Outlook
 
Management provided an outlook for the full year of 2022, ending Dec. 31, 2022. Based on current estimates, management expects:
 
Revenue between $445 million and $450 million
 
*Non-GAAP gross margin between 83% and 85%
 
*Non-GAAP income from operations between $214 million and $217 million
 
*Non-GAAP earnings per diluted share between $2.28 and $2.30
 
This outlook is not a guarantee of future performance and stockholders should not rely on such forward-looking statements. See “Forward-Looking Statements” for additional information.
 
*Please refer to “Use of Non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP financial results exclude share-based compensation adjustments.
 
Use of Non-GAAP Financial Measures
 
In addition to InMode’s operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, and non-GAAP operating margin. Because these measures are used in InMode’s internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode’s economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode’s GAAP operating results, allows investors to more effectively evaluate and compare InMode’s performance to that of its peers, although InMode’s presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.
 
Conference Call Information
 
Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer, Mr. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, Chief Medical Officer, will host a conference call today, Oct. 27, 2022, at 8:30 a.m. Eastern Time to discuss the third quarter 2022 financial results.
 
The Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10171927/f4b117e67a

Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

For callers that opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

U.S. Toll-Free Dial-in Number: 1-833-316-0562
Israel Toll- Free Dial-in Number: 1-80-921-2373
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=pOSyfnXi
At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
3:30 p.m. Israel Time


The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from October 27, 2022, at 12 p.m. Eastern Time to November 02, 2022, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

Replay Dial-in U.S TOLL-FREE: 1-877-344-7529
Replay Dial-in Canada TOLL-FREE: 855-669-9658
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 8851334

To access the replay using an international dial-in number, please select the link below: https://services.choruscall.com/ccforms/replay.html

A replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.

About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode’s future financial or operating performance, including the future performance described above under the heading titled “2021 Financial Outlook.” Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict, including with respect to the impact of the COVID-19 global outbreak. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2022, as well as risk factors relating to the COVID-19 global outbreak and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
 
Company Contact:
Yair Malca
Chief Financial Officer
Phone: (949) 305-0108
Email: Yair.Malca@inmodemd.com
Investor Relations Contact:
Miri Segal
MS-IR LLC
Phone: (917) 607-8654
Email: ir@inmodemd.com



INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended
September 30,
   
Nine months ended
September 30,
 
   
2022
   
2021
   
2022
   
2021
 
REVENUES
   
121,232
     
94,176
     
320,700
     
247,025
 
COST OF REVENUES
   
18,765
     
13,943
     
52,483
     
36,745
 
GROSS PROFIT
   
102,467
     
80,233
     
268,217
     
210,280
 
OPERATING EXPENSES:
                               
Research and development
   
3,166
     
2,248
     
9,164
     
7,004
 
Sales and marketing
   
43,062
     
30,835
     
113,564
     
84,067
 
General and administrative
   
2,494
     
2,132
     
7,533
     
5,884
 
TOTAL OPERATING EXPENSES
   
48,722
     
35,215
     
130,261
     
96,955
 
INCOME FROM OPERATIONS
   
53,745
     
45,018
     
137,956
     
113,325
 
Finance income (expenses), net
   
189
     
(65
)
   
(350
)
   
407
 
INCOME BEFORE TAXES
   
53,934
     
44,953
     
137,606
     
113,732
 
INCOME TAXES
   
5,145
     
235
     
13,794
     
1,343
 
NET INCOME
   
48,789
     
44,718
     
123,812
     
112,389
 
Add: Net income attributable to non-controlling interests
   
-
     
-
     
-
     
(103
)
NET INCOME ATTRIBUTABLE TO INMODE LTD.
   
48,789
     
44,718
     
123,812
     
112,286
 
                                 
NET INCOME PER SHARE:
                               
Basic
   
0.59
     
0.54
     
1.50
     
1.39
 
Diluted
   
0.58
     
0.52
     
1.45
     
1.31
 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)
                               
Basic
   
82,306
     
82,705
     
82,494
     
80,843
 
Diluted
   
84,823
     
86,264
     
85,120
     
85,802
 


INMODE LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
September 30,
2022
   
December 31,
2021
 
Assets
           
CURRENT ASSETS:
           
Cash and cash equivalents
   
77,048
     
68,136
 
Marketable securities
   
334,934
     
294,530
 
Short-term bank deposits
   
74,405
     
53,248
 
Accounts receivable, net of allowance for doubtful accounts
   
28,056
     
20,236
 
Other receivables
   
13,730
     
12,938
 
Inventories
   
35,810
     
21,026
 
TOTAL CURRENT ASSETS
   
563,983
     
470,114
 
NON-CURRENT ASSETS:
               
Accounts receivable
   
3,766
     
768
 
Deferred income taxes, net
   
3,255
     
1,334
 
Operating lease right-of-use assets
   
5,191
     
4,321
 
Property and equipment, net
   
2,189
     
1,404
 
Other investments
   
600
     
600
 
TOTAL NON-CURRENT ASSETS
   
15,001
     
8,427
 
TOTAL ASSETS
   
578,984
     
478,541
 
Liabilities and shareholders’ equity
               
CURRENT LIABILITIES:
               
Accounts payable
   
13,296
     
8,779
 
Contract liabilities
   
12,450
     
13,805
 
Other liabilities
   
32,181
     
29,266
 
TOTAL CURRENT LIABILITIES
   
57,927
     
51,850
 
NON-CURRENT LIABILITIES:
               
Contract liabilities
   
3,647
     
2,751
 
Other liabilities
   
5,450
     
4,831
 
Operating lease liabilities
   
3,657
     
3,307
 
TOTAL NON-CURRENT LIABILITIES
   
12,754
     
10,889
 
TOTAL LIABILITIES
   
70,681
     
62,739
 
                 
TOTAL SHAREHOLDERS’ EQUITY
   
508,303
     
415,802
 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
   
578,984
     
478,541
 



INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended
September 30,
   
Nine months ended
September 30,
 
   
2022
   
2021
   
2022
   
2021
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                       
Net income
   
48,789
     
44,718
     
123,812
     
112,389
 
Adjustments required to reconcile net income to net cash provided by operating activities:
                               
Depreciation and amortization
   
169
     
136
     
462
     
378
 
Share-based compensation expenses
   
7,857
     
3,192
     
17,304
     
8,838
 
Allowance for doubtful accounts
   
50
     
48
     
402
     
375
 
Loss on marketable securities, net
   
12
     
26
     
49
     
33
 
Finance expenses, net
   
586
     
789
     
1,527
     
1,598
 
Deferred income taxes, net
   
9
     
(189
)
   
156
     
(391
)
Changes in operating assets and liabilities:
                               
Increase in accounts receivable
   
(6,926
)
   
(4,403
)
   
(11,220
)
   
(12,478
)
Decrease (increase) in other receivables
   
887
     
(4,101
)
   
(706
)
   
(4,418
)
Increase in inventories
   
(6,050
)
   
(1,784
)
   
(14,784
)
   
(4,195
)
Increase in accounts payable
   
1,463
     
1,161
     
4,517
     
2,474
 
Increase in other liabilities
   
4,136
     
11,157
     
3,366
     
16,194
 
Increase (decrease) in contract liabilities
   
(5,390
)
   
(277
)
   
(459
)
   
1,195
 
Net cash provided by operating activities
   
45,592
     
50,473
     
124,426
     
121,992
 
CASH FLOWS FROM INVESTING ACTIVITIES:
                               
Investment in short-term deposits
   
(48,090
)
   
(25,090
)
   
(93,701
)
   
(66,090
)
Proceeds from short-term deposits
   
30,090
     
24,090
     
73,090
     
62,180
 
Purchase of fixed assets
   
(387
)
   
(254
)
   
(1,247
)
   
(757
)
Purchase of marketable securities
   
(58,982
)
   
(77,547
)
   
(97,736
)
   
(203,274
)
Proceeds from sale of marketable securities
   
21,236
     
30,660
     
48,395
     
78,642
 
Net cash (used in) investing activities
   
(56,133
)
   
(48,141
)
   
(71,199
)
   
(129,299
)
CASH FLOWS FROM FINANCING ACTIVITIES:
                               
Repurchase of ordinary shares
   
-
     
-
     
(42,637
)
   
(11,921
)
Exercise of options
   
550
     
5,200
     
915
     
19,803
 
Net cash provided by (used in) financing activities
   
550
     
5,200
     
(41,722
)
   
7,882
 
EFFECT OF EXCHANGE RATE CHANGES ON CASH
   
(1,365
)
   
(376
)
   
(2,593
)
   
(585
)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
   
(11,356
)
   
7,156
     
8,912
     
(10
)
                                 
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
   
88,404
     
61,772
     
68,136
     
68,938
 
CASH AND CASH EQUIVALENTS AT END OF PERIOD
   
77,048
     
68,928
     
77,048
     
68,928
 



INMODE LTD.
CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended September 30,
   
Nine months ended September 30,
 
   
2022
   
2021
    2022    
2021
 
Revenues by Category:
                                               
                                                 
Capital Equipment revenues - United States
   
72,920
     
60
%
   
56,284
     
60
%
   
180,640
     
57
%
   
144,614
     
58
%
Capital Equipment revenues - International
   
34,383
     
28
%
   
28,783
     
30
%
   
97,126
     
30
%
   
76,030
     
31
%
Total Capital Equipment revenues
   
107,303
     
88
%
   
85,067
     
90
%
   
277,766
     
87
%
   
220,644
     
89
%
Consumables and service revenues
   
13,929
     
12
%
   
9,109
     
10
%
   
42,934
     
13
%
   
26,381
     
11
%
Total Net Revenue
   
121,232
     
100
%
   
94,176
     
100
%
   
320,700
     
100
%
   
247,025
     
100
%

 
Three months ended September 30,
   
Nine months ended September 30,
 

 
2022
   
2021
   
2022
   
2021
 
   
%
   
%
   
%
   
%
 
   
United States
   
International
   
Total
   
United States
   
International
   
Total
   
United States
   
International
   
Total
   
United States
   
International
   
Total
 
Revenues by Technology:
                                                                       
Minimally Invasive
   
84
     
75
     
82
     
73
     
73
     
73
     
84
     
73
     
80
     
70
     
74
     
71
 
Hands-Free
   
13
     
8
     
11
     
25
     
5
     
18
     
13
     
7
     
11
     
28
     
7
     
21
 
Non-Invasive
   
3
     
17
     
7
     
2
     
22
     
9
     
3
     
20
     
9
     
2
     
19
     
8
 
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
 



INMODE LTD.
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
 INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)

 
Three months ended September 30, 2022
   
Three months ended September 30, 2021
 
   
GAAP
   
Share Based
Compensation
   
Non-GAAP
   
GAAP
   
Share Based
Compensation
   
Non-GAAP
 
REVENUES
   
121,232
           
121,232
     
94,176
     
-
     
94,176
 
COST OF REVENUES
   
18,765
     
(554
)
   
18,211
     
13,943
     
(301
)
   
13,642
 
GROSS PROFIT
   
102,467
     
554
     
103,021
     
80,233
     
301
     
80,534
 
OPERATING EXPENSES:
                                               
Research and development
   
3,166
     
(857
)
   
2,309
     
2,248
     
(425
)
   
1,823
 
Sales and marketing
   
43,062
     
(5,879
)
   
37,183
     
30,835
     
(2,208
)
   
28,627
 
General and administrative
   
2,494
     
(567
)
   
1,927
     
2,132
     
(258
)
   
1,874
 
TOTAL OPERATING
EXPENSES
   
48,722
     
(7,303
)
   
41,419
     
35,215
     
(2,891
)
   
32,324
 
INCOME FROM OPERATIONS
   
53,745
     
7,857
     
61,602
     
45,018
     
3,192
     
48,210
 
Finance income (expenses), net
   
189
     
-
     
189
     
(65
)
   
-
     
(65
)
INCOME BEFORE TAXES
   
53,934
     
7,857
     
61,791
     
44,953
     
3,192
     
48,145
 
INCOME TAXES
   
5,145
     
-
     
5,145
     
235
     
-
     
235
 
NET INCOME
   
48,789
     
7,857
     
56,646
     
44,718
     
3,192
     
47,910
 
                                                 
NET INCOME PER SHARE:
                                               
Basic
   
0.59
             
0.69
     
0.54
             
0.58
 
Diluted
   
0.58
             
0.66
     
0.52
             
0.55
 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)
                                               
Basic
   
82,306
             
82,306
     
82,705
             
82,705
 
Diluted
   
84,823
             
85,453
     
86,264
             
86,494
 


INMODE LTD.
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
 INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)

 
Nine months ended September 30, 2022
   
Nine months ended September 30, 2021
 
   
GAAP
   
Share Based
Compensation
   
Non-GAAP
   
GAAP
   
Share Based
Compensation
   
Non-GAAP
 
REVENUES
   
320,700
     
-
     
320,700
     
247,025
     
-
     
247,025
 
COST OF REVENUES
   
52,483
     
(1,364
)
   
51,119
     
36,745
     
(804
)
   
35,941
 
GROSS PROFIT
   
268,217
     
1,364
     
269,581
     
210,280
     
804
     
211,084
 
OPERATING EXPENSES:
                                               
Research and development
   
9,164
     
(2,248
)
   
6,916
     
7,004
     
(1,112
)
   
5,892
 
Sales and marketing
   
113,564
     
(12,233
)
   
101,331
     
84,067
     
(6,154
)
   
77,913
 
General and administrative
   
7,533
     
(1,459
)
   
6,074
     
5,884
     
(768
)
   
5,116
 
TOTAL OPERATING
EXPENSES
   
130,261
     
(15,940
)
   
114,321
     
96,955
     
(8,034
)
   
88,921
 
INCOME FROM OPERATIONS
   
137,956
     
17,304
     
155,260
     
113,325
     
8,838
     
122,163
 
Finance income (expenses), net
   
(350
)
   
-
     
(350
)
   
407
     
-
     
407
 
INCOME BEFORE TAXES
   
137,606
     
17,304
     
154,910
     
113,732
     
8,838
     
122,570
 
INCOME TAXES
   
13,794
     
-
     
13,794
     
1,343
     
-
     
1,343
 
NET INCOME
   
123,812
     
17,304
     
141,116
     
112,389
     
8,838
     
121,227
 
Add: Net Income attributable to non-controlling interests
   
-
     
-
     
-
     
(103
)
   
-
     
(103
)
NET INCOME ATTRIBUTABLE TO INMODE LTD.
   
123,812
     
17,304
     
141,116
     
112,286
     
8,838
     
121,124
 
                                                 
NET INCOME PER SHARE:
                                               
Basic
   
1.50
             
1.71
     
1.39
             
1.50
 
Diluted
   
1.45
             
1.65
     
1.31
             
1.41
 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)
                                               
Basic
   
82,494
             
82,494
     
80,843
             
80,843
 
Diluted
   
85,120
             
85,667
     
85,802
             
86,059